Stryker entered into an agreement to distribute AlloSource biologic products in the U.S. for use in sports medicine procedures.
We expect that Stryker will continue to launch products and collaborate in the arthroscopy/soft tissue and orthobiologics spaces to boost its sports medicine portfolio. Leadership has noted that, while sports medicine is a small portion of the company’s revenue, it’s “growing very fast.” Stryker’s 2015, 2016 and 1Q17 revenue for arthroscopy/soft tissue and orthobiolgics can be found here.
Sources: AlloSource; ORTHOWORLD Inc.
Stryker entered into an agreement to distribute AlloSource biologic products in the U.S. for use in sports medicine procedures.
We expect that Stryker will continue to launch products and collaborate in the arthroscopy/soft tissue and orthobiologics spaces to boost its sports medicine portfolio. Leadership has noted that, while sports...
Stryker entered into an agreement to distribute AlloSource biologic products in the U.S. for use in sports medicine procedures.
We expect that Stryker will continue to launch products and collaborate in the arthroscopy/soft tissue and orthobiologics spaces to boost its sports medicine portfolio. Leadership has noted that, while sports medicine is a small portion of the company’s revenue, it’s “growing very fast.” Stryker’s 2015, 2016 and 1Q17 revenue for arthroscopy/soft tissue and orthobiolgics can be found here.
Sources: AlloSource; ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.